Results 121 to 130 of about 701 (179)

High-resolution laser spectroscopy of singly charged natural uranium isotopes. [PDF]

Sci Rep
Raggio A, Block M, Campbell P, Cheal B, de Groote RP, Gins W, Koszorús Á, Moore ID, Ortiz-Cortes A, Pohjalainen I, Warbinek J.   +10 more
europepmc   +1 more source

Technetium-99 determination in low-volume samples from the global environment with accelerator mass spectrometry.

Env Sci Adv
Hain K, Adler S, Faestermann T, Fifield LK, Froehlich MB, Gülce F, Koll D, Korschinek G, Martschini M, Quinto F, Pavetich S, Pitters J, Rugel G, Tims S, Welch J, Wiederin A, Yamada M.   +16 more
europepmc   +1 more source

Enhancing shielding efficiency of ordinary and barite concrete in radiation shielding utilizations. [PDF]

Sci Rep
Ahmad N, Idris MI, Hussin A, Abdul Karim J, Azreen NM, Zainon R.   +5 more
europepmc   +1 more source

A long-lived impact-generated hydrothermal system at the Chicxulub impact structure. [PDF]

Commun Earth Environ
Pickersgill AE, Christou E, Tremblay MM, Barfod DN, Rasmussen C, Lee MR, Schmieder M, Collins GS, Dymock R, Gulick SPS, Kring DA, Morgan JV, Osinski GR, Swindle T, Tikoo SM, Wittmann A, Expedition 364 Scientists, Mark DF.   +17 more
europepmc   +1 more source

A true theranostic pair - ^44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer. [PDF]

Eur J Nucl Med Mol Imaging
Kumar N, Bilinska A, Menéndez E, Läppchen T, Moon ES, Zoltowska M, Pawlak D, Cieszykowska I, Mikolajczak R, Rösch F, Rominger A, Gourni E.   +11 more
europepmc   +1 more source

¹⁶¹Tb-PSMA radioligand therapy in prostate cancer: current evidence and future perspectives. [PDF]

Front Oncol
Xiao L, Zhao Z, Luo R, Liu F, Hu B, Zhao P, Yang X, Chen Z.   +7 more
europepmc   +1 more source

[⁶⁸Ga]Ga-DOTAGA-Glu(FAPi)₂ Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging. [PDF]

Diagnostics (Basel)
Mortensen JVK, Mattiussi S, Hvass L, Lund EG, Shalgunov V, Roesch F, Battisti UM, Herth MM, Kjaer A.   +8 more
europepmc   +1 more source

Predictive factors of oral mucositis in patients with locally recurrent inoperable head and neck cancer treated with boron neutron capture therapy. [PDF]

Acta Oncol
Mälkiä T, Koivunoro H, Seppälä T, Kankaanranta L, Porra L, Anttonen A, Tenhunen M, Joensuu H.   +7 more
europepmc   +1 more source

Preclinical evaluation of DOTAGA.Glu.(FAPI)₂ and DO3A.Glu.(FAPI)₂ as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs. [PDF]

Eur J Nucl Med Mol Imaging
Bilinska A, Kumar N, Gnesin S, Läppchen T, Menéndez E, Martin M, Rösch F, Rominger A, Gourni E.   +8 more
europepmc   +1 more source

Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the ⁶⁸Ga- and ¹⁷⁷Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)₂. [PDF]

Molecules
Läppchen T, Bilinska A, Pilatis E, Menéndez E, Imlimthan S, Moon ES, Afshar-Oromieh A, Rösch F, Rominger A, Gourni E.   +9 more
europepmc   +1 more source